Alexandre Colau

Groupe Hospitalier Diaconesses Croix Saint-Simon

Papers

1

Total Citations

10

H-Index

1

About

Alexandre Colau is a urological researcher whose work centers on refining treatment strategies for prostate cancer, with a particular focus on advancing focal therapy as a precision alternative to radical interventions. His major contribution lies in addressing the critical challenge of patient selection for focal therapy, a minimally invasive approach that targets only clinically significant prostate cancer lesions while sparing healthy tissue. In his highly cited 2022 study, "The Challenges of Patient Selection for Prostate Cancer Focal Therapy," Colau led a retrospective observational multicentre analysis that identified predictive factors for treatment failure, directly tackling the overtreatment dilemma stemming from increased diagnoses of silent prostate cancer. This work, which has garnered 10 citations, provides actionable insights for urologists seeking to balance oncologic control with quality of life by minimizing functional side effects. Colau’s research is pivotal for moving beyond one-size-fits-all approaches, offering a framework to personalize therapy based on tumor characteristics. His efforts underscore a commitment to evidence-based, patient-centered care, making him a notable voice in the evolving landscape of prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
The Challenges of Patient Selection for Prostate Cancer Focal Therapy: A Retrospective Observational Multicentre Study
10 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Groupe Hospitalier Diaconesses Croix Saint-Simon

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago